Capital Project Engineering in Pharma Summit Wyndham Boston Beacon Hill, Boston

The surge in demand for speed-to-market patient delivery of drugs is exponential, meaning that the pressure to develop new drug-development sites is now more prominent than ever before. Excitement in the field is evident: Novartis has invested in 3 new manufacturing sites, BMS is scaling up production for Breyanzi, and Thermo Fisher has opened a 300,000 ft² viral vector production site in Boston.

The Capital Project Engineering in Pharma Summit will cover new-builds, brownfields and expansion projects – enabling Project Managers and Engineers to achieve operational readiness on these projects. Join us and learn how to incorporate an adaptable project design, mitigate risks from the get go, and handle equipment with optimal efficiency. This unique event is the only pharma-specific and end-user led meeting focused on bridging internal and external stakeholders to deliver new sites on time and on budget.